Published Date: Jul 20 2021
On the meeting, the headquarter of Gene-Biocon has summarized of the work in the first half of the year. He said that: "With the cooperation of all staff of our company, Gene-Biocon has not only exceeded the sales task in the first half of 2021, and the sales performance doubled year-on-year, also break through the limitation of technology, especially in the R&D of fourth generation long-acting express insulin, the peptide products of cosmetic and the application of patents.
Gene-Biocon always focus on research and development Biomedicine, bioengineering enzymes, cell growth factors and cosmetic peptides, aiming to provide products with high quality and best service, to protect the profit of our customers.
There are two methods what we do to know more about our customers and provide a better service for them.
1. The detection information of products is more safety and transparency, to help the customers finished the filing effectively---by providing multiple third-party product safety testing, efficacy testing and quality testing reports, efficiently assist customers to improve the product filing process
2. Diversified data marketing, to increase customer stickiness-----Through the integration of existing online and offline channels, combined with the sales needs of various regions, diversified management has been deepened and developed.
Meanwhile, we also pay attention to promote products from different ways, such as the product features, local culture,and preferences of customers.
Whatever Gene-Biocon has spare no effort to pursuit a better development and then to serve more customers.
